DGDavid K. Gaffney
David K. Gaffney
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
David K. Gaffney has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Joseph Holden
3 shared publicationsAlexander Tsodikov
2 shared publicationsKaren Zempolich
2 shared publicationsLynn Smith
Department of Radiation Oncology, University of Utah, Salt Lake City, UT, USA
2 shared publicationsMark Dodson
2 shared publicationsA.P. Brown
1 shared publication
Latest Publications
- 1 November 2010
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 78 (3) , S145
Survival Analysis of FIGO Stage IIIC Endometrial Cancer Patients
- 1 November 2010
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 78 (3) , S145
Survival Analysis of FIGO Stage IIIC Endometrial Cancer Patients
- Open Access
- 28 January 2005
- Published by Wiley in American Journal of Hematology
- Vol. 78 (2) , 151-152
Intracranial extramedullary hematopoiesis: Brief review of response to radiation therapy
- 28 January 2005
- Published by Wiley in American Journal of Hematology
- Vol. 78 (2) , 151-152
Open AccessIntracranial extramedullary hematopoiesis: Brief review of response to radiation therapy
- 1 April 2004
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 58 (5) , 1474-1479
Does radiotherapy around the time of pregnancy for Hodgkin's disease modify the risk of breast cancer?*1
- 1 April 2004
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 58 (5) , 1474-1479
Does radiotherapy around the time of pregnancy for Hodgkin's disease modify the risk of breast cancer?*1
- 1 July 2003
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 56 (4) , 922-928
Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy
- 1 July 2003
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 56 (4) , 922-928
Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy
- 1 November 2001
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 51 (4) , 994-1001
Electron arc irradiation of the postmastectomy chest wall with CT treatment planning: 20-year experience
- 1 November 2001
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 51 (4) , 994-1001
Electron arc irradiation of the postmastectomy chest wall with CT treatment planning: 20-year experience
- 1 April 2001
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 49 (5) , 1213-1217
Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy
- 1 April 2001
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 49 (5) , 1213-1217
Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy
- 1 February 2001
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 49 (2) , 539-546
Breast cancer after mantle irradiation for Hodgkin’s disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2
- 1 February 2001
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 49 (2) , 539-546
Breast cancer after mantle irradiation for Hodgkin’s disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2